Astrocyte-derived growth factors and estrogen neuroprotection: Role of transforming growth factor-α in estrogen-induced upregulation of glutamate transporters in astrocytes

Molecular and Cellular Endocrinology

Volumn 389, Issue 1-2, 2014, Pages 58-64

  Karki, Pratap ^a   Smith, Keisha ^a   Johnson, James ^a   Lee, Eunsook ^a  

^a MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

Astrocytes; Estrogen; GLAST; GLT 1; Neuroprotection; TGF

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; EXCITATORY AMINO ACID TRANSPORTER; G PROTEIN COUPLED RECEPTOR 30; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MANGANESE; MESSENGER RNA; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; TRANSFORMING GROWTH FACTOR ALPHA; VESICULAR GLUTAMATE TRANSPORTER 1; NEUROPROTECTIVE AGENT; SIGNAL PEPTIDE;

ASTROCYTE; CELL FUNCTION; CELL SURVIVAL; DEGENERATIVE DISEASE; DISEASE COURSE; DRUG MECHANISM; ESTROGEN ACTIVITY; EXCITOTOXICITY; GENE EXPRESSION; HUMAN; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; UPREGULATION; ANIMAL; METABOLISM;

AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; ASTROCYTES; ESTROGENS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEUROPROTECTIVE AGENTS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TRANSFORMING GROWTH FACTOR ALPHA; UP-REGULATION;

EID: 84901478804     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.01.010     Document Type: Review

References (103)

1. Abdelhamid R., Luo J., Vandevrede L., Kundu I., Michalsen B., Litosh V.A., Schiefer I.T., Gherezghiher T., Yao P., Qin Z., et al. Benzothiophene selective estrogen receptor modulators provide neuroprotection by a novel GPR30-dependent mechanism. ACS Chem. Neurosci. 2011, 2:256-268.
2. Allen N.J., Barres B.A. Neuroscience: glia - more than just brain glue. Nature 2009, 457:675-677.
3. Azcoitia I., Santos-Galindo M., Arevalo M.A., Garcia-Segura L.M. Role of astroglia in the neuroplastic and neuroprotective actions of estradiol. Eur. J. Neurosci. 2010, 32:1995-2002.
4. Bao Y.J., Li L.Z., Li X.G., Wang Y.J. 17Beta-estradiol differentially protects cortical pericontusional zone from programmed cell death after traumatic cerebral contusion at distinct stages via non-genomic and genomic pathways. Mol. Cell. Neurosci. 2011, 48:185-194.
5. Barreto G., White R.E., Ouyang Y., Xu L., Giffard R.G. Astrocytes: targets for neuroprotection in stroke. Cent. Nerv. Syst. Agents Med. Chem. 2011, 11:164-173.
6. Beck T., Lindholm D., Castren E., Wree A. Brain-derived neurotrophic factor protects against ischemic cell damage in rat hippocampus. J. Cereb. Blood Flow Metab. 1994, 14:689-692.
7. Behl C. Oestrogen as a neuroprotective hormone. Nat. Rev. Neurosci. 2002, 3:433-442.
8. Bonnefont A.B., Munoz F.J., Inestrosa N.C. Estrogen protects neuronal cells from the cytotoxicity induced by acetylcholinesterase-amyloid complexes. FEBS Lett. 1998, 441:220-224.
9. Bowman A.B., Kwakye G.F., Hernandez E.H., Aschner M. Role of manganese in neurodegenerative diseases. J. Trace. Elem. Med. Biol. 2011, 25:191-203.
10. Brann D.W., Dhandapani K., Wakade C., Mahesh V.B., Khan M.M. Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications. Steroids 2007, 72:381-405.
11. Buchanan C.D., Mahesh V.B., Brann D.W. Estrogen-astrocyte-luteinizing hormone-releasing hormone signaling: a role for transforming growth factor-beta(1). Biol. Reprod. 2000, 62:1710-1721.
12. Choi Y.C., Lee J.H., Hong K.W., Lee K.S. 17 Beta-estradiol prevents focal cerebral ischemic damages via activation of Akt and CREB in association with reduced PTEN phosphorylation in rats. Fundam. Clin. Pharmacol. 2004, 18:547-557.
13. Clarke L.E., Barres B.A. Emerging roles of astrocytes in neural circuit development. Nat. Rev. Neurosci. 2013, 14:311-321.
14. Dhandapani K.M., Brann D.W. Estrogen-astrocyte interactions: implications for neuroprotection. BMC Neurosci. 2002, 3:6.
15. Dhandapani K., Brann D. Neuroprotective effects of estrogen and tamoxifen in vitro: a facilitative role for glia?. Endocrine 2003, 21:59-66.
16. Dhandapani K.M., Brann D.W. Role of astrocytes in estrogen-mediated neuroprotection. Exp. Gerontol. 2007, 42:70-75.
17. Dhandapani K.M., Hadman M., De Sevilla L., Wade M.F., Mahesh V.B., Brann D.W. Astrocyte protection of neurons: role of transforming growth factor-beta signaling via a c-Jun-AP-1 protective pathway. J. Biol. Chem. 2003, 278:43329-43339.
18. Dhandapani K.M., Wade F.M., Mahesh V.B., Brann D.W. Astrocyte-derived transforming growth factor-{beta} mediates the neuroprotective effects of 17{beta}-estradiol: involvement of nonclassical genomic signaling pathways. Endocrinology 2005, 146:2749-2759.
19. Dobolyi A., Vincze C., Pal G., Lovas G. The neuroprotective functions of transforming growth factor Beta proteins. Int. J. Mol. Sci. 2012, 13:8219-8258.
20. Dobson A.W., Erikson K.M., Aschner M. Manganese neurotoxicity. Ann. N. Y. Acad. Sci. 2004, 1012:115-128.
21. Dubal D.B., Kashon M.L., Pettigrew L.C., Ren J.M., Finklestein S.P., Rau S.W., Wise P.M. Estradiol protects against ischemic injury. J. Cereb. Blood. Flow Metab. 1998, 18:1253-1258.
22. Dubal D.B., Zhu H., Yu J., Rau S.W., Shughrue P.J., Merchenthaler I., Kindy M.S., Wise P.M. Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc. Natl. Acad. Sci. USA 2001, 98:1952-1957.
23. Dubal D.B., Rau S.W., Shughrue P.J., Zhu H., Yu J., Cashion A.B., Suzuki S., Gerhold L.M., Bottner M.B., Dubal S.B., et al. Differential modulation of estrogen receptors (ERs) in ischemic brain injury: a role for ERalpha in estradiol-mediated protection against delayed cell death. Endocrinology 2006, 147:3076-3084.
24. Duenas M., Luquin S., Chowen J.A., Torres-Aleman I., Naftolin F., Garcia-Segura L.M. Gonadal hormone regulation of insulin-like growth factor-I-like immunoreactivity in hypothalamic astroglia of developing and adult rats. Neuroendocrinology 1994, 59:528-538.
25. Elzer J.G., Muhammad S., Wintermantel T.M., Regnier-Vigouroux A., Ludwig J., Schutz G., Schwaninger M. Neuronal estrogen receptor-alpha mediates neuroprotection by 17beta-estradiol. J. Cereb. Blood Flow Metab. 2010, 30:935-942.
26. Farr T.D., Carswell H.V., Gsell W., Macrae I.M. Estrogen receptor beta agonist diarylpropiolnitrile (DPN) does not mediate neuroprotection in a rat model of permanent focal ischemia. Brain Res. 2007, 1185:275-282.
27. Fitzpatrick J.L., Mize A.L., Wade C.B., Harris J.A., Shapiro R.A., Dorsa D.M. Estrogen-mediated neuroprotection against beta-amyloid toxicity requires expression of estrogen receptor alpha or beta and activation of the MAPK pathway. J. Neurochem. 2002, 82:674-682.
28. Flores C., Salmaso N., Cain S., Rodaros D., Stewart J. Ovariectomy of adult rats leads to increased expression of astrocytic basic fibroblast growth factor in the ventral tegmental area and in dopaminergic projection regions of the entorhinal and prefrontal cortex. J. Neurosci. 1999, 19:8665-8673.
29. Galbiati M., Martini L., Melcangi R.C. Oestrogens, via transforming growth factor alpha, modulate basic fibroblast growth factor synthesis in hypothalamic astrocytes: in vitro observations. J. Neuroendocrinol. 2002, 14:829-835.
30. Garcia-Segura L.M., Naftolin F., Hutchison J.B., Azcoitia I., Chowen J.A. Role of astroglia in estrogen regulation of synaptic plasticity and brain repair. J. Neurobiol. 1999, 40:574-584.
31. Garcia-Segura L.M., Azcoitia I., DonCarlos L.L. Neuroprotection by estradiol. Prog. Neurobiol. 2001, 63:29-60.
32. Gingerich S., Kim G.L., Chalmers J.A., Koletar M.M., Wang X., Wang Y., Belsham D.D. Estrogen receptor alpha and G-protein coupled receptor 30 mediate the neuroprotective effects of 17beta-estradiol in novel murine hippocampal cell models. Neuroscience 2010, 170:54-66.
33. Gollapudi L., Oblinger M.M. Estrogen and NGF synergistically protect terminally differentiated, ERalpha-transfected PC12 cells from apoptosis. J. Neurosci. Res. 1999, 56:471-481.
34. Green P.S., Simpkins J.W. Neuroprotective effects of estrogens: potential mechanisms of action. Int. J. Dev. Neurosci. 2000, 18:347-358.
35. Hamby M.E., Sofroniew M.V. Reactive astrocytes as therapeutic targets for CNS disorders. Neurotherapeutics 2010, 7:494-506.
36. Jordan V.C. Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer. Br. J. Pharmacol. 2006, 147(Suppl. 1):S269-S276.
37. Jover-Mengual T., Zukin R.S., Etgen A.M. MAPK signaling is critical to estradiol protection of CA1 neurons in global ischemia. Endocrinology 2007, 148:1131-1143.
38. Jover-Mengual T., Miyawaki T., Latuszek A., Alborch E., Zukin R.S., Etgen A.M. Acute estradiol protects CA1 neurons from ischemia-induced apoptotic cell death via the PI3K/Akt pathway. Brain Res. 2010, 1321:1-12.
39. Junier M.P. What role(s) for TGFalpha in the central nervous system?. Prog. Neurobiol. 2000, 62:443-473.
40. Karki P., Webb A., Smith K., Lee K., Son D.S., Aschner M., Lee E. CREB and NF-kappaB mediate the tamoxifen-induced upregulation of GLT-1 in rat astrocytes. J. Biol. Chem. 2013.
41. Kazanis I., Giannakopoulou M., Philippidis H., Stylianopoulou F. Alterations in IGF-I, BDNF and NT-3 levels following experimental brain trauma and the effect of IGF-I administration. Exp. Neurol. 2004, 186:221-234.
42. Kelly M.J., Ronnekleiv O.K. Control of CNS neuronal excitability by estrogens via membrane-initiated signaling. Mol. Cell. Endocrinol. 2009, 308:17-25.
43. Kim K., Lee S.G., Kegelman T.P., Su Z.Z., Das S.K., Dash R., Dasgupta S., Barral P.M., Hedvat M., Diaz P., et al. Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. J. Cell. Physiol. 2011, 226:2484-2493.
44. Kimelberg H.K., Feustel P.J., Jin Y., Paquette J., Boulos A., Keller R.W., Tranmer B.I. Acute treatment with tamoxifen reduces ischemic damage following middle cerebral artery occlusion. NeuroReport 2000, 11:2675-2679.
45. Kirschner P.B., Henshaw R., Weise J., Trubetskoy V., Finklestein S., Schulz J.B., Beal M.F. Basic fibroblast growth factor protects against excitotoxicity and chemical hypoxia in both neonatal and adult rats. J. Cereb. Blood Flow Metab. 1995, 15:619-623.
46. Kuo J., Hamid N., Bondar G., Prossnitz E.R., Micevych P. Membrane estrogen receptors stimulate intracellular calcium release and progesterone synthesis in hypothalamic astrocytes. J. Neurosci. 2010, 30:12950-12957.
47. Lebesgue D., Chevaleyre V., Zukin R.S., Etgen A.M. Estradiol rescues neurons from global ischemia-induced cell death: multiple cellular pathways of neuroprotection. Steroids 2009, 74:555-561.
48. Lebesgue D., Traub M., De Butte-Smith M., Chen C., Zukin R.S., Kelly M.J., Etgen A.M. Acute administration of non-classical estrogen receptor agonists attenuates ischemia-induced hippocampal neuron loss in middle-aged female rats. PLoS ONE 2010, 5:e8642.
49. Lee S.J., McEwen B.S. Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. Annu. Rev. Pharmacol. Toxicol. 2001, 41:569-591.
50. Lee E.S., Sidoryk M., Jiang H., Yin Z., Aschner M. Estrogen and tamoxifen reverse manganese-induced glutamate transporter impairment in astrocytes. J. Neurochem. 2009, 110:530-544.
51. Lee E.S., Yin Z., Milatovic D., Jiang H., Aschner M. Estrogen and tamoxifen protect against Mn-induced toxicity in rat cortical primary cultures of neurons and astrocytes. Toxicol. Sci. 2009, 110:156-167.
52. Lee E., Sidoryk-Wegrzynowicz M., Wang N., Webb A., Son D.S., Lee K., Aschner M. GPR30 regulates glutamate transporter GLT-1 expression in rat primary astrocytes. J. Biol. Chem. 2012, 287:26817-26828.
53. Lee E., Sidoryk-Wegrzynowicz M., Yin Z., Webb A., Son D.S., Aschner M. Transforming growth factor-alpha mediates estrogen-induced upregulation of glutamate transporter GLT-1 in rat primary astrocytes. Glia 2012, 60:1024-1036.
54. Liang Z., Valla J., Sefidvash-Hockley S., Rogers J., Li R. Effects of estrogen treatment on glutamate uptake in cultured human astrocytes derived from cortex of Alzheimer's disease patients. J. Neurochem. 2002, 80:807-814.
55. Lin C.L., Kong Q., Cuny G.D., Glicksman M.A. Glutamate transporter EAAT2: a new target for the treatment of neurodegenerative diseases. Future Med. Chem. 2012, 4:1689-1700.
56. Littleton-Kearney M.T., Ostrowski N.L., Cox D.A., Rossberg M.I., Hurn P.D. Selective estrogen receptor modulators: tissue actions and potential for CNS protection. CNS Drug Rev. 2002, 8:309-330.
57. Liu S.B., Han J., Zhang N., Tian Z., Li X.B., Zhao M.G. Neuroprotective effects of oestrogen against oxidative toxicity through activation of G-protein-coupled receptor 30 receptor. Clin. Exp. Pharmacol. Physiol. 2011, 38:577-585.
58. Liu S.B., Zhang N., Guo Y.Y., Zhao R., Shi T.Y., Feng S.F., Wang S.Q., Yang Q., Li X.Q., Wu Y.M., et al. G-protein-coupled receptor 30 mediates rapid neuroprotective effects of estrogen via depression of NR2B-containing NMDA receptors. J. Neurosci. 2012, 32:4887-4900.
59. Ma Y.J., Berg-von der Emde K., Moholt-Siebert M., Hill D.F., Ojeda S.R. Region-specific regulation of transforming growth factor alpha (TGF alpha) gene expression in astrocytes of the neuroendocrine brain. J. Neurosci. 1994, 14:5644-5651.
60. Mahesh V.B., Dhandapani K.M., Brann D.W. Role of astrocytes in reproduction and neuroprotection. Mol. Cell. Endocrinol. 2006, 246:1-9.
61. Marin R., Diaz M., Alonso R., Sanz A., Arevalo M.A., Garcia-Segura L.M. Role of estrogen receptor alpha in membrane-initiated signaling in neural cells: interaction with IGF-1 receptor. J. Steroid Biochem. Mol. Biol. 2009, 114:2-7.
62. Marino M., Galluzzo P., Ascenzi P. Estrogen signaling multiple pathways to impact gene transcription. Curr. Genomics 2006, 7:497-508.
63. Mendez P., Cardona-Gomez G.P., Garcia-Segura L.M. Interactions of insulin-like growth factor-I and estrogen in the brain. Adv. Exp. Med. Biol. 2005, 567:285-303.
64. Nicole O., Ali C., Docagne F., Plawinski L., MacKenzie E.T., Vivien D., Buisson A. Neuroprotection mediated by glial cell line-derived neurotrophic factor: involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathway. J. Neurosci. 2001, 21:3024-3033.
65. Nozaki K., Finklestein S.P., Beal M.F. Basic fibroblast growth factor protects against hypoxia-ischemia and NMDA neurotoxicity in neonatal rats. J. Cereb. Blood Flow Metab. 1993, 13:221-228.
66. Osuka K., Feustel P.J., Mongin A.A., Tranmer B.I., Kimelberg H.K. Tamoxifen inhibits nitrotyrosine formation after reversible middle cerebral artery occlusion in the rat. J. Neurochem. 2001, 76:1842-1850.
67. Pal P.K., Samii A., Calne D.B. Manganese neurotoxicity: a review of clinical features, imaging and pathology. Neurotoxicology 1999, 20:227-238.
68. Park L.C.H., Zhang H., Gibson G.E. Co-culture with astrocytes or microglia protects metabolically impaired neurons. Mech. Ageing Dev. 2001, 123:21-27.
69. Pawlak J., Brito V., Kuppers E., Beyer C. Regulation of glutamate transporter GLAST and GLT-1 expression in astrocytes by estrogen. Brain Res. Mol. Brain Res. 2005, 138:1-7.
70. Pawlak J., Karolczak M., Krust A., Chambon P., Beyer C. Estrogen receptor-alpha is associated with the plasma membrane of astrocytes and coupled to the MAP/Src-kinase pathway. Glia 2005, 50:270-275.
71. Platania P., Seminara G., Aronica E., Troost D., Vincenza Catania M., Angela Sortino M. 17beta-estradiol rescues spinal motoneurons from AMPA-induced toxicity: a role for glial cells. Neurobiol. Dis. 2005, 20:461-470.
72. Regan R.F., Guo Y. Estrogens attenuate neuronal injury due to hemoglobin, chemical hypoxia, and excitatory amino acids in murine cortical cultures. Brain Res. 1997, 764:133-140.
73. Rosenberg P.A., Aizenman E. Hundred-fold increase in neuronal vulnerability to glutamate toxicity in astrocyte-poor cultures of rat cerebral cortex. Neurosci. Lett. 1989, 103:162-168.
74. Rothstein J.D., Van Kammen M., Levey A.I., Martin L.J., Kuncl R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 1995, 38:73-84.
75. Sama M.A., Mathis D.M., Furman J.L., Abdul H.M., Artiushin I.A., Kraner S.D., Norris C.M. Interleukin-1beta-dependent signaling between astrocytes and neurons depends critically on astrocytic calcineurin/NFAT activity. J. Biol. Chem. 2008, 283:21953-21964.
76. Sampei K., Goto S., Alkayed N.J., BJ Crain, Korach K.S., Traystman R.J., Demas G.E., Nelson R.J., Hurn P.D. Stroke in estrogen receptor-alpha-deficient mice. Stroke 2000, 31:738-43. (discussion 744).
77. Sawada M., Alkayed N.J., Goto S., Crain B.J., Traystman R.J., Shaivitz A., Nelson R.J., Hurn P.D. Estrogen receptor antagonist ICI182,780 exacerbates ischemic injury in female mouse. J. Cereb. Blood Flow Metab. 2000, 20:112-118.
78. Simoncini T., Hafezi-Moghadam A., Brazil D.P., Ley K., Chin W.W., Liao J.K. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 2000, 407:538-541.
79. Simpkins J.W., Singh M., Brock C., Etgen A.M. Neuroprotection and estrogen receptors. Neuroendocrinology 2012, 96:119-130.
80. Singer C.A., Rogers K.L., Strickland T.M., Dorsa D.M. Estrogen protects primary cortical neurons from glutamate toxicity. Neurosci. Lett. 1996, 212:13-16.
81. Singer C.A., Figueroa-Masot X.A., Batchelor R.H., Dorsa D.M. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J. Neurosci. 1999, 19:2455-2463.
82. Sitcheran R., Gupta P., Fisher P.B., Baldwin A.S. Positive and negative regulation of EAAT2 by NF-kappaB: a role for N-myc in TNFalpha-controlled repression. Embo J. 2005, 24:510-520.
83. Sohrabji F., Lewis D.K. Estrogen-BDNF interactions: implications for neurodegenerative diseases. Front. Neuroendocrinol. 2006, 27:404-414.
84. Sortino M.A., Chisari M., Merlo S., Vancheri C., Caruso M., Nicoletti F., Canonico P.L., Copani A. Glia mediates the neuroprotective action of estradiol on beta-amyloid-induced neuronal death. Endocrinology 2004, 145:5080-5086.
85. Sortino M.A., Platania P., Chisari M., Merlo S., Copani A., Catania M.V. A major role for astrocytes in the neuroprotective effect of estrogen. Drug Dev. Res. 2005, 66:126-135.
86. Spence R.D., Hamby M.E., Umeda E., Itoh N., Du S., Wisdom A.J., Cao Y., Bondar G., Lam J., Ao Y., et al. Neuroprotection mediated through estrogen receptor-alpha in astrocytes. Proc. Natl. Acad. Sci. USA 2011, 108:8867-8872.
87. Spence R.D., Wisdom A.J., Cao Y., Hill H.M., Mongerson C.R., Stapornkul B., Itoh N., Sofroniew M.V., Voskuhl R.R. Estrogen mediates neuroprotection and anti-inflammatory effects during EAE through ERalpha signaling on astrocytes but not through ERbeta signaling on astrocytes or neurons. J. Neurosci. 2013, 33:10924-10933.
88. Su Z.Z., Leszczyniecka M., Kang D.C., Sarkar D., Chao W., Volsky D.J., Fisher P.B. Insights into glutamate transport regulation in human astrocytes: cloning of the promoter for excitatory amino acid transporter 2 (EAAT2). Proc. Natl. Acad. Sci. USA 2003, 100:1955-1960.
89. Sudo S., Wen T.C., Desaki J., Matsuda S., Tanaka J., Arai T., Maeda N., Sakanaka M. Beta-estradiol protects hippocampal CA1 neurons against transient forebrain ischemia in gerbil. Neurosci. Res. 1997, 29:345-354.
90. Svendsen C.N. The amazing astrocyte. Nature 2002, 417:29-32.
91. Ullian E.M., Christopherson K.S., Barres B.A. Role for glia in synaptogenesis. Glia 2004, 47:209-216.
92. Vedder H., Anthes N., Stumm G., Wurz C., Behl C., Krieg J.C. Estrogen hormones reduce lipid peroxidation in cells and tissues of the central nervous system. J. Neurochem. 1999, 72:2531-2538.
93. Vegeto E., Benedusi V., Maggi A. Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases. Front. Neuroendocrinol. 2008, 29:507-519.
94. Wang L., Andersson S., Warner M., Gustafsson J.A. Morphological abnormalities in the brains of estrogen receptor beta knockout mice. Proc. Natl. Acad. Sci. USA 2001, 98:2792-2796.
95. White R.E., Rao M., Gensel J.C., McTigue D.M., Kaspar B.K., Jakeman L.B. Transforming growth factor alpha transforms astrocytes to a growth-supportive phenotype after spinal cord injury. J. Neurosci. 2011, 31:15173-15187.
96. Wise P.M. Estrogens and neuroprotection. Trends Endocrinol. Metab. 2002, 13:229-230.
97. Xu S.L., Bi C.W., Choi R.C., Zhu K.Y., Miernisha A., Dong T.T., Tsim K.W. Flavonoids induce the synthesis and secretion of neurotrophic factors in cultured rat astrocytes: a signaling response mediated by estrogen receptor. Evid. Based Complement. Alternat. Med. 2013, 2013:127075.
98. Yamashita K., Wiessner C., Lindholm D., Thoenen H., Hossmann K.A. Post-occlusion treatment with BDNF reduces infarct size in a model of permanent occlusion of the middle cerebral artery in rat. Metab. Brain Dis. 1997, 12:271-280.
99. Yang L.C., Zhang Q.G., Zhou C.F., Yang F., Zhang Y.D., Wang R.M., Brann D.W. Extranuclear estrogen receptors mediate the neuroprotective effects of estrogen in the rat hippocampus. PLoS ONE 2010, 5:e9851.
100. Zhang Y., Barres B.A. Astrocyte heterogeneity: an underappreciated topic in neurobiology. Curr. Opin. Neurobiol. 2010, 20:588-594.
101. Zhang Q.G., Han D., Wang R.M., Dong Y., Yang F., Vadlamudi R.K., Brann D.W. C terminus of Hsc70-interacting protein (CHIP)-mediated degradation of hippocampal estrogen receptor-alpha and the critical period hypothesis of estrogen neuroprotection. Proc. Natl. Acad. Sci. USA 2011, 108:E617-E624.
102. Zhao L., Brinton R.D. Estrogen receptor alpha and beta differentially regulate intracellular Ca(2+) dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons. Brain Res. 2007, 1172:48-59.
103. Zhao L., Wu T.W., Brinton R.D. Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons. Brain Res. 2004, 1010:22-34.